These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Protein expression and clinical significance of cyclooxygenase 2 and nuclear factor kappa B in gastric mucosa-associated lymphoid tissue lymphoma]. Wu XL; Han SL; Wan L; Huang KT Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):163-6. PubMed ID: 18344086 [TBL] [Abstract][Full Text] [Related]
5. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173 [TBL] [Abstract][Full Text] [Related]
6. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma. Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146 [TBL] [Abstract][Full Text] [Related]
7. Expression of FOXP1 in mucosa-associated lymphoid tissue lymphoma suggests a large tumor cell transformation and predicts a poorer prognosis in the positive thyroid patients. Jiang W; Li L; Tang Y; Zhang WY; Liu WP; Li GD Med Oncol; 2012 Dec; 29(5):3352-9. PubMed ID: 22736042 [TBL] [Abstract][Full Text] [Related]
8. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas. Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121 [TBL] [Abstract][Full Text] [Related]
9. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. Omonishi K; Yoshino T; Sakuma I; Kobayashi K; Moriyama M; Akagi T Mod Pathol; 1998 Feb; 11(2):181-5. PubMed ID: 9504689 [TBL] [Abstract][Full Text] [Related]
10. Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type. Zhai L; Zhao Y; Ye S; Huang H; Tian Y; Wu Q; Lin H; Lin T Tumour Biol; 2011 Oct; 32(5):913-20. PubMed ID: 21660567 [TBL] [Abstract][Full Text] [Related]
11. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1. Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL. He M; Gao L; Zhang S; Tao L; Wang J; Yang J; Zhu M Gastric Cancer; 2014; 17(3):431-41. PubMed ID: 24232982 [TBL] [Abstract][Full Text] [Related]
13. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Dogan A; Du M; Koulis A; Briskin MJ; Isaacson PG Am J Pathol; 1997 Nov; 151(5):1361-9. PubMed ID: 9358762 [TBL] [Abstract][Full Text] [Related]
14. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis. Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of CD23 expression in paraffin-embedded gastric lymphomas of mucosa-associated lymphoid tissue. Kroft SH; Hsi ED; Ross CW; Schnitzer B; Singleton TP Mod Pathol; 1998 Oct; 11(10):967-70. PubMed ID: 9796724 [TBL] [Abstract][Full Text] [Related]
16. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797 [TBL] [Abstract][Full Text] [Related]
17. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression. Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822 [TBL] [Abstract][Full Text] [Related]
18. Reassessment of gastric lymphoma in light of the concept of mucosa-associated lymphoid tissue lymphoma: analysis of 53 patients. Hoshida Y; Kusakabe H; Furukawa H; Kasugai T; Miwa H; Ishiguro S; Aozasa K Cancer; 1997 Sep; 80(6):1151-9. PubMed ID: 9305717 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas. Go JH; Yang WI; Ree HJ Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050 [TBL] [Abstract][Full Text] [Related]
20. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB. Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]